Werewolf Therapeutics HOWL SEC Filings

NASDAQ HOWL
$1.03 -0.02 (-1.90%)
At close: Oct 21, 2026 · 4:00 PM EDT
EDGAR Disclosures

SEC Filings

Source SEC EDGAR

Every SEC filing Werewolf Therapeutics, Inc. (HOWL) has made, as reported on EDGAR — annual and quarterly reports, current reports, insider transactions and ownership disclosures. Filter by form group, form type or period, and open any filing or its index directly.

Form Type
# Form Type Form Group Accession Date Filing Index
1S-4Prospectus0001140361-26-037334Sep 22, 2026 9:04 PM
2425Others0001193125-26-360063Aug 21, 2026 1:12 PM
38-KCurrent Report0001193125-26-360059Aug 21, 2026 1:10 PM
48-KCurrent Report0001193125-26-359185Aug 20, 2026 8:06 PM
510-QQuarterly & Annual Report0001785530-26-000019Jul 31, 2026 11:10 AM
68-KCurrent Report0001785530-26-000018Jul 31, 2026 11:06 AM
74Insider Transaction0001134657-26-000020Jul 8, 2026 9:34 PM
8144Insider Transaction0001628280-26-047367Jul 6, 2026 9:19 PM
9144Insider Transaction0001628280-26-047366Jul 6, 2026 9:19 PM
10144Insider Transaction0001628280-26-047365Jul 6, 2026 9:19 PM
11144Insider Transaction0001628280-26-047364Jul 6, 2026 9:18 PM
12144Insider Transaction0001628280-26-047362Jul 6, 2026 9:18 PM
13144Insider Transaction0001628280-26-047360Jul 6, 2026 9:18 PM
14SCHEDULE 13DBeneficial Ownership Report0001346824-26-000187Jul 2, 2026 12:26 AM
154Insider Transaction0001134657-26-000019Jun 29, 2026 11:07 PM
16144Insider Transaction0001628280-26-046087Jun 29, 2026 9:30 PM
17144Insider Transaction0001628280-26-046086Jun 29, 2026 9:30 PM
18144Insider Transaction0001628280-26-046085Jun 29, 2026 9:29 PM
19144Insider Transaction0001628280-26-046084Jun 29, 2026 9:29 PM
20144Insider Transaction0001628280-26-046083Jun 29, 2026 9:29 PM
21144Insider Transaction0001628280-26-046082Jun 29, 2026 9:29 PM
22SCHEDULE 13DBeneficial Ownership Report0001346824-26-000185Jun 26, 2026 9:39 PM
23SCHEDULE 13DBeneficial Ownership Report0001346824-26-000180Jun 22, 2026 11:02 PM
244Insider Transaction0001231919-26-000688Jun 22, 2026 10:59 PM
254Insider Transaction0001231919-26-000654Jun 16, 2026 10:01 PM
26SCHEDULE 13DBeneficial Ownership Report0001346824-26-000175Jun 15, 2026 12:16 AM
274Insider Transaction0001231919-26-000628Jun 11, 2026 12:13 AM
284Insider Transaction0001134657-26-000018Jun 10, 2026 9:20 PM
294Insider Transaction0001134657-26-000017Jun 8, 2026 10:13 PM
304Insider Transaction0001134657-26-000016Jun 3, 2026 10:42 PM
314Insider Transaction0001134657-26-000015May 29, 2026 10:51 PM
32144Insider Transaction0001628280-26-038896May 28, 2026 9:04 PM
33144Insider Transaction0001628280-26-038895May 28, 2026 9:03 PM
34144Insider Transaction0001628280-26-038893May 28, 2026 9:03 PM
35144Insider Transaction0001628280-26-038892May 28, 2026 9:03 PM
36144Insider Transaction0001628280-26-038891May 28, 2026 9:03 PM
37144Insider Transaction0001628280-26-038889May 28, 2026 9:02 PM
384Insider Transaction0001134657-26-000012May 20, 2026 10:08 PM
39144Insider Transaction0001628280-26-036039May 18, 2026 5:03 PM
40144Insider Transaction0001628280-26-036038May 18, 2026 5:02 PM
41144Insider Transaction0001628280-26-036037May 18, 2026 5:02 PM
42144Insider Transaction0001628280-26-036035May 18, 2026 5:02 PM
43144Insider Transaction0001628280-26-036033May 18, 2026 5:01 PM
44144Insider Transaction0001628280-26-036032May 18, 2026 5:01 PM
454Insider Transaction0001134657-26-000011May 13, 2026 8:06 PM
46SCHEDULE 13DBeneficial Ownership Report0001609492-26-000006May 12, 2026 11:56 PM
474Insider Transaction0001134657-26-000010May 12, 2026 11:47 PM
484Insider Transaction0001231919-26-000485May 12, 2026 10:26 PM
49144Insider Transaction0001628280-26-033579May 11, 2026 8:33 PM
50144Insider Transaction0001628280-26-033579May 11, 2026 8:33 PM
...

Werewolf Therapeutics, Inc. SEC Filings API

Pull Werewolf Therapeutics, Inc.'s SEC filing index, with links to every filing and exhibit, into your own tools with the Business Quant SEC Filings API. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/secfilings?ticker=HOWL&formtype=10-K,10-Q&api_key=YOUR_API_KEY